| Name | [6-(2-nitrophenyl)imidazo[2,1-b][1,3]thiazol-3-yl]methanol |
|---|---|
| Synonyms |
(6-(2-nitrophenyl)imidazo[2,1-b]thiazol-3-yl)methanol
[6-(2-Nitrophenyl)imidazo[2,1-b][1,3]thiazol-3-yl]methanol 3-Hydroxymethyl-6-(2-nitrophenyl)imidazo[2,1-b]thiazole Imidazo[2,1-b]thiazole-3-methanol, 6-(2-nitrophenyl)- |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C12H9N3O3S |
| Molecular Weight | 275.283 |
| Exact Mass | 275.036469 |
| PSA | 111.59000 |
| LogP | 2.69 |
| Index of Refraction | 1.765 |
| HS Code | 2934100090 |
|---|
|
~71%
925437-85-0 |
| Literature: Sirtris Pharmaceuticals, Inc. Patent: US2010/215632 A1, 2010 ; |
|
~76%
925437-85-0 |
| Literature: Sirtris Pharmaceuticals, Inc. Patent: US2008/249103 A1, 2008 ; Location in patent: Page/Page column 35 ; US 20080249103 A1 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |